Viewing Study NCT06457061


Ignite Creation Date: 2025-12-24 @ 11:51 AM
Ignite Modification Date: 2025-12-31 @ 3:57 PM
Study NCT ID: NCT06457061
Status: COMPLETED
Last Update Posted: 2024-06-13
First Post: 2024-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Caregiver Burden and Depression Severity in Patients With Hemiplegia
Sponsor: Abant Izzet Baysal University
Organization:

Study Overview

Official Title: Evaluation of Caregiver Burden and Depression Severity in Patients With Right and Left Hemiplegia
Status: COMPLETED
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aimed to evaluate the caregiving burden and severity of depression in patients with right hemiplegia and left hemiplegia.
Detailed Description: Stroke is a disease characterized by neurological symptoms and signs lasting more than 24 hours, which can lead to death after the interruption of brain blood flow or due to focal brain damage. Post-stroke disability affects the patient's quality of life, makes the patient dependent on the caregiver, creates a caregiver burden, and brings socioeconomic and social consequences. Different hemispheres of the brain undertake different tasks. Different clinical conditions may occur in stroke patients with right or left hemiplegia following cerebrovascular infarction. This may affect the care burden of caregivers and the severity of depression. It was thought that knowing the care burden of patients with right and left hemiplegia would positively contribute to the quality of care given to patients.This study aimed to evaluate the caregiving burden and severity of depression in patients with right hemiplegia and left hemiplegia.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: